Abstract |
We examined the association between the gene expression levels of glutathione S-transferase-pi (GST-pi) and platinum drug exposure in human lung cancer. First we monitored GST-pi gene expression levels in two lung cancer cell lines and in peripheral mononuclear cells of ten previously untreated lung cancer patients after platinum drug exposure. Next we examined GST-pi gene expression levels in 40 lung cancer autopsy specimens. The GST-pi gene expression levels were assessed by the quantitative reverse transcription-polymerase chain reaction or Northern blot analysis. The GST-pi gene expression was not induced by platinum drugs either in vitro and in vivo within 24 h of exposure. In contrast, GST-pi gene expression levels in lung cancer tissues of patients who had been exposed to platinum drugs at least 1 month before death were significantly higher than that in those of patients who had not been exposed. These results suggest that GST-pi gene expression is associated with chronic exposure to platinum drugs in lung cancer and/or the stress response to xenobiotics.
|
Authors | T Oguri, Y Fujiwara, O Katoh, H Daga, N Ishikawa, K Fujitaka, M Yamasaki, M Yokozaki, T Isobe, S Ishioka, M Yamakido |
Journal | Cancer letters
(Cancer Lett)
Vol. 156
Issue 1
Pg. 93-9
(Aug 01 2000)
ISSN: 0304-3835 [Print] Ireland |
PMID | 10840164
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Isoenzymes
- Organoplatinum Compounds
- Transcription Factor AP-1
- GSTP1 protein, human
- Glutathione S-Transferase pi
- Glutathione Transferase
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Gene Expression Regulation, Enzymologic
- Glutathione S-Transferase pi
- Glutathione Transferase
(genetics, physiology)
- Humans
- Isoenzymes
(genetics, physiology)
- Lung Neoplasms
(drug therapy, enzymology, genetics)
- Organoplatinum Compounds
(metabolism, pharmacology)
- Transcription Factor AP-1
(physiology)
- Tumor Cells, Cultured
|